Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: BeyondSpring Pharmaceuticals Inc.
Condition: Chemotherapy-induced Neutropenia
NCT04345900
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.